The Indian pharmaceutical industry is upgrading its operations in response to tighter regulations and increased scrutiny from drug regulators. And that will lead to better, more competitive products, according to Sun Pharmaceutical Industries Ltd. Chairman Israel Makov. “Yes, it is a pressure, but it is a ...
Read more: Davos WEF 2018: Sun Pharma Chairman Says US FDA Scrutiny Will Lead To Better Products